Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis.

Abstract

In this cohort, adverse events were not very different from those seen in patients on either treatment alone and the combination of leflunomide plus infliximab did not appear to be as badly tolerated as described in a previous study.